A Modified Spacer Device For Inhalational Drug Therapy For Chronic Bronchitis/Asthma In Laryngectomised Patients
CLINICAL OTOLARYNGOLOGY(2000)
Abstract
Following total laryngectomy, patients who need to continue their inhalational drug therapy for chronic pulmonary conditions experience a great deal of difficulty in administering the drugs. We describe a new spacer device to deliver inhalational drug therapy to laryngectomized patients which is simple to use and does not interfere with the patient's life style. The device involves a standard metered dose inhaler, a paediatric face mask and a small volume spacer. This device was used successfully in six laryngectomised patients for 12-18 months, who needed to continue their inhalational drug therapy for their pulmonary condition.
MoreTranslated text
Key words
modified spacer device, inhalational drugs, laryngectomy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined